Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in March 2026 (Volume 29, Issue 3) Submit manuscript

A clinical study to evaluate the efficacy of Amalaki Churna in Pandu Vyadhi with special reference to Iron Deficiency Anaemia

Breadcrumb

  • Home
  • A clinical study to evaluate the efficacy of Amalaki Churna in Pandu Vyadhi with special reference to Iron Deficiency Anaemia

Sachinkumar Sahebrao Patil *

Department of Kayachikitsa, M.A.M.’s Sumatibhai Shah Ayurved Mahavidyala, Malwadi, Hadapasar, Pune - 411028, Maharashtra State, India.
 
Research Article
World Journal of Advanced Research and Reviews, 2022, 16(03), 1108-1111
Article DOI: 10.30574/wjarr.2022.16.3.1484
DOI url: https://doi.org/10.30574/wjarr.2022.16.3.1484
Received on 19 November 2022; revised on 26 December 2022; accepted on 29 December 2022
 
Iron Deficiency Anaemia (IDA) is the most common type of Anaemia overall, and is caused when the dietary intake or absorption of Iron is insufficient. According to National family health survey, India report Anaemia affects an estimated 50% of the Indian population.[1] Rasayana Chikitsa is very beneficial to the patient of Pandu (IDA). In these diseases, the Saarta(essence) of all dhatus is lost hence the dhatus becomes Nissari.e., loss of qualitative physiological excellence, which ultimately results in Oja-Kshaya.[2] Here 30 patients were selected randomly in the study and given Amalaki Churna in 3 gms/day. At the end of 30 days symptomatic improvement and increase in Hb% in Group were noticed. No significant therapy is there for chronic Anaemias in Modern science, which are often due to metabolic defect, so an attempt has been made to evaluate the efficacy of Amalaki Churna on Iron Deficiency Anaemia. It is reported that this drug has useful role in preventing Iron deficiency Anaemia due to metabolic defect. 
 
Panduroga; Iron Deficiency Anaemia; Anaemia; Rasayana; Amalaki
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2022-1484.pdf

Preview Article PDF

Sachinkumar Sahebrao Patil. A clinical study to evaluate the efficacy of Amalaki Churna in Pandu Vyadhi with special reference to Iron Deficiency Anaemia. World Journal of Advanced Research and Reviews, 2022, 16(3), 1108-1111. Article DOI: https://doi.org/10.30574/wjarr.2022.16.3.1484

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution